# Bio-Interfaces, Inc.

- Location (FDA's records): San Diego, CA
- FDA decisions: 17 (1989–1996): 17 510(k) clearances
- Product codes: LYC (15), EID (1), DZE (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- The Straumann Co.: 1 (https://510kreport.com/company/straumann)

## Its most-cited devices
- K960164: Bio-Interfaces, Inc., Bioresorbable Calcium Phosphate Particles - Bii-Graft 6140 (1996), cited by 1

## Recent decisions
- K960164: Bio-Interfaces, Inc., Bioresorbable Calcium Phosphate Particles - Bii-Graft 6140 (Apr 10, 1996)
- K954763: Bio-Interfaces, Inc,. Bii-Plast (Jan 4, 1996)
- K950598: Bioresorbable Calcium Phosphate Particles - BLL-Graft (Aug 23, 1995)
- K950567: Bio-Apatite 6140 HA Particles (May 9, 1995)
- K950511: BLL-Fil 6140 Particles (Apr 27, 1995)
- K934049: Bii-Pore (TM) Canal Wall Prosthesis (Jul 19, 1994)
- K933688: Bii-Pore (Jul 19, 1994)
- K941431: Bone Graft Delivery Syringes (Jul 12, 1994)

Source page: https://510kreport.com/company/bio-interfaces
